MPNEatDIA

Wednesday, 6 April 2016

DIA2016


DIA Europe is taking place in Hamburg 6- 8th April 2016 and we have just arrived! 

Violeta and Bettina 

Posted by Bettina at 07:08
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Newer Post Home
Subscribe to: Post Comments (Atom)

Contributors

  • Bettina
  • Violeta Astratinei

Blog Archive

  • ▼  2016 (14)
    • ▼  April (14)
      • Oxford debate: this house believes that over engi...
      • IMI2 project ADAPT SMART
      • Start-ups with regulatory and industry- small bio...
      • Adaptive Pathways and conditional approval
      • Why involve patients in Rare Disease Research Th...
      • Innovative ways of involving patients in RD The ...
      • Shall HTA depend on RCT (randomised controlled tri...
      • What are the challenges of conducting pragmatic t...
      • How well can the pre-launch study design provide ...
      • Real World Evidence in Drug Development Chris C...
      • The needs of the payers shape the evidence for ma...
      • Opening Plenary Session INNovation- do you win by ...
      • Regulatory Town Hall meeting
      • DIA2016
Simple theme. Powered by Blogger.